BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26070687)

  • 1. Efficient production of safety-enhanced Escherichia coli ghosts by tandem expression of PhiX 174 mutant gene E and staphylococcal nuclease A gene.
    Zhu W; Zhang Y; Liu X
    Microbiol Res; 2015 Jul; 176():7-13. PubMed ID: 26070687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of safety enhanced Edwardsiella tarda ghost vaccine.
    Lee DJ; Kwon SR; Zenke K; Lee EH; Nam YK; Kim SK; Kim KH
    Dis Aquat Organ; 2008 Sep; 81(3):249-54. PubMed ID: 18998589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escherichia coli ghost production by expression of lysis gene E and Staphylococcal nuclease.
    Haidinger W; Mayr UB; Szostak MP; Resch S; Lubitz W
    Appl Environ Microbiol; 2003 Oct; 69(10):6106-13. PubMed ID: 14532068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Vibrio anguillarum ghost by coexpression of PhiX 174 lysis E gene and staphylococcal nuclease A gene.
    Kwon SR; Kang YJ; Lee DJ; Lee EH; Nam YK; Kim SK; Kim KH
    Mol Biotechnol; 2009 Jun; 42(2):154-9. PubMed ID: 19191038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel dual vector coexpressing PhiX174 lysis E gene and staphylococcal nuclease A gene on the basis of lambda promoter pR and pL, respectively.
    Fu L; Lu C
    Mol Biotechnol; 2013 Jun; 54(2):436-44. PubMed ID: 22782703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of effects of staphylococcal nuclease A fused with different exogenous DNA fragments].
    Fu L; Ji D; Lu X; Han X; Wei W
    Sheng Wu Gong Cheng Xue Bao; 2016 Dec; 32(12):1654-1663. PubMed ID: 29034633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of bacteriolysis of shuffled phage PhiX174 gene E.
    Yu SY; Peng W; Si W; Yin L; Liu SG; Liu HF; Zhao HL; Wang CL; Chang YH; Lin YZ
    Virol J; 2011 May; 8():206. PubMed ID: 21548934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mutation of lambdapL/pR-cI857 system for production of bacterial ghost in Escherichia coli].
    Dong H; Han X; Bai H; He L; Liu L; Liu R; Chai T; Ding C; Liu H; Yu S
    Sheng Wu Gong Cheng Xue Bao; 2012 Dec; 28(12):1423-30. PubMed ID: 23593866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modified Escherichia coli protein production strain expressing staphylococcal nuclease, capable of auto-hydrolysing host nucleic acid.
    Cooke GD; Cranenburgh RM; Hanak JA; Ward JM
    J Biotechnol; 2003 Mar; 101(3):229-39. PubMed ID: 12615392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice vaccinated with enteropathogenic Escherichia coli ghosts show significant protection against lethal challenges.
    Liu J; Wang WD; Liu YJ; Liu S; Zhou B; Zhu LW; Ji X; Sun Y; Feng SZ
    Lett Appl Microbiol; 2012 Mar; 54(3):255-62. PubMed ID: 22211792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth and productivity impacts of periplasmic nuclease expression in an Escherichia coli Fab' fragment production strain.
    Nesbeth DN; Perez-Pardo MA; Ali S; Ward J; Keshavarz-Moore E
    Biotechnol Bioeng; 2012 Feb; 109(2):517-27. PubMed ID: 21898368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery.
    Jalava K; Eko FO; Riedmann E; Lubitz W
    Expert Rev Vaccines; 2003 Feb; 2(1):45-51. PubMed ID: 12901596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmid DNA production combining antibiotic-free selection, inducible high yield fermentation, and novel autolytic purification.
    Carnes AE; Hodgson CP; Luke JM; Vincent JM; Williams JA
    Biotechnol Bioeng; 2009 Oct; 104(3):505-15. PubMed ID: 19557837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a safety enhanced Salmonella Gallinarum ghost using antibiotic resistance free plasmid and its potential as an effective inactivated vaccine candidate against fowl typhoid.
    Jawale CV; Chaudhari AA; Lee JH
    Vaccine; 2014 Feb; 32(9):1093-9. PubMed ID: 24406393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a novel vector system for programmed cell lysis in Escherichia coli.
    Yun J; Park J; Park N; Kang S; Ryu S
    J Microbiol Biotechnol; 2007 Jul; 17(7):1162-8. PubMed ID: 18051328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sealed bacterial ghosts--novel targeting vehicles for advanced drug delivery of water-soluble substances.
    Paukner S; Kohl G; Jalava K; Lubitz W
    J Drug Target; 2003 Apr; 11(3):151-61. PubMed ID: 13129825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and nuclease activity analysis of staphylococcus nuclease in E.coli].
    Qin CF; Qin ED; Yu M; Jiang T; Chen SP; Deng YQ; Duan HY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):513-5. PubMed ID: 15989805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New shuttle vector-based expression system to generate polyhistidine-tagged fusion proteins in Staphylococcus aureus and Escherichia coli.
    Schwendener S; Perreten V
    Appl Environ Microbiol; 2015 May; 81(9):3243-54. PubMed ID: 25747000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minicircle DNA immobilized in bacterial ghosts: in vivo production of safe non-viral DNA delivery vehicles.
    Jechlinger W; Azimpour Tabrizi C; Lubitz W; Mayrhofer P
    J Mol Microbiol Biotechnol; 2004; 8(4):222-31. PubMed ID: 16179799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a recombinant gene product and growth conditions on plasmid stability in pectinolytic Escherichia coli cells.
    Tierny Y; Hounsa CG; Hornez JP
    Microbios; 1999; 97(386):39-53. PubMed ID: 10413867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.